Physician profile
Robin Ochei
NPI 1548889694
$1,317.39
in general payments reported to CMS, 2019-2025
22 companies · $856 in 2025
The $856 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $171 · 2024: $290 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $170.98 | 2023 | Cobalt Dr Mri Surescan |
| Bayer Healthcare Pharmaceuticals INC. | $164.65 | 2024-2025 | |
| Novo Nordisk INC | $141.66 | 2024-2025 | Wegovy, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $129.55 | 2025 | Entyvio |
| Novartis Pharmaceuticals Corporation | $120.57 | 2024-2025 | |
| Exact Sciences Corporation | $91.13 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $78.19 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $56.50 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amgen INC. | $50.16 | 2024-2025 | Evenity, Repatha, Otezla |
| Exeltis, USA INC. | $40.71 | 2024-2025 | Slynd |
| Ani Pharmaceuticals, INC. | $29.85 | 2025 | Purified Cortrophin Gel |
| Medicomp INC | $26.57 | 2024 | Telepatch Cardiac Monitor |
| Lilly USA, LLC | $25.73 | 2024 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $25.03 | 2025 | Gemtesa |
| Astellas Pharma US INC | $24.28 | 2025 | Veozah |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $23.90 | 2025 | Ibsrela |
| Celltrion USA INC. | $22.71 | 2025 | Vegzelma |
| Glaxosmithkline, LLC. | $22.40 | 2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $20.36 | 2025 | Wainua |
| Mannkind Corporation | $18.45 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $17.40 | 2025 | Rhythm Express |
| Inspire Medical Systems, INC. | $16.61 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Ochei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.